等待开盘 10-02 09:30:00 美东时间
+0.340
+1.28%
Amphastar Pharmaceuticals ( ($AMPH) ) just unveiled an update. On September 15,...
09-19 05:19
-SEC Filing
09-19 04:52
Amneal Pharmaceuticals近日宣布其Sodium oxybate口服溶液500 mg/mL仿制药获得美国FDA批准,该药参考Jazz Pharmaceuticals的Xyrem,用于治疗7岁及以上narcolepsy患者的cataplexy或过度日间嗜睡。这是FDA批准的首个Sodium oxybate仿制药,将扩大Amneal平价药品系列,并提升患者获得治疗的机会。Sodium oxybate作为narcolepsy的标准治疗药物,可改善夜间睡眠并显著减少cataplexy发作。Amneal此举将为患者、医疗提供者和支付方提供更实惠的选择。
09-11 12:00
B of A Securities analyst Jason Gerberry maintains Amphastar Pharma (NASDAQ:AMPH) with a Neutral and raises the price target from $28 to $32.
08-26 23:23
Amphastar Pharmaceuticals (NASDAQ:AMPH) has entered into an exclusive license agreement with Nanjing Anji Biotechnology for the development, manufacturing, use, and commercialization of three propriet...
08-12 19:39
Piper Sandler analyst David Amsellem maintains Amphastar Pharma (NASDAQ:AMPH) with a Neutral and lowers the price target from $30 to $25.
08-08 19:25
Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.76 by 11.99 percent. This is a 9.57 percent decrease over earnings of $0.94 per share from the
08-08 04:09
Amphastar Pharmaceuticals Q2 EPS USD 0.64
08-08 04:05
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33